RxDoctor Payments Data

Nathan Tomita, DO

Surgery · Kailua Kona, HINPI 1255312401

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 66.4% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $14,944 and has fallen 93.4% since, to $986 in 2025. Among surgery clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$34,231in general payments, 2019–2025

Across 164 payments — averaging $208.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$23K
  • Endogastric Solutions, Inc$8K
  • Medtronic$879
  • Organogenesis Inc.$651
  • Covidien LP$609
  • Boston Scientific$334
  • plus $1K from 16 others
$99,546in research payments, 2019–2025

Across 6 payments — averaging $16,591 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$71K
  • Reddress LTD$28K

What the payments were for

  • Consulting fees$14,65943%
  • Travel & lodging$3,52110%
  • Food & beverage$15,96847%
  • Entertainment$830%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,231 in reported general payments places this provider in the 95th percentile of 109 surgery providers in Hawaii.

See all surgery providers in Hawaii

Medicare billing

Part B allowed, 2024
$787,761
Medicare patients
207
Services billed
1,252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin23$178
Ciprofloxacin Hcl18$144
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim27$122

Paid to pharmacies, not to this prescriber.

Other surgery in Kailua Kona

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →